(NASDAQ: IRTC) Irhythm Technologies's forecast annual revenue growth rate of 18.57% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.65%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.2%.
Irhythm Technologies's revenue in 2024 is $492,681,000.On average, 5 Wall Street analysts forecast IRTC's revenue for 2024 to be $17,998,635,553, with the lowest IRTC revenue forecast at $17,971,715,000, and the highest IRTC revenue forecast at $18,063,288,250. On average, 5 Wall Street analysts forecast IRTC's revenue for 2025 to be $21,357,694,780, with the lowest IRTC revenue forecast at $21,097,782,883, and the highest IRTC revenue forecast at $21,653,232,265.
In 2026, IRTC is forecast to generate $25,096,863,539 in revenue, with the lowest revenue forecast at $24,316,167,506 and the highest revenue forecast at $25,877,559,572.